The Biohacking market size is valued at USD 27.5 Bn in 2026.
The Biohacking market is projected to grow at a CAGR of 17% by 2033.
The Biohacking market growth drivers include rising adoption of smart drugs, advancements in genetic engineering, and growing health and wellness awareness.
North America is a dominating region for the Biohacking market.
Apple Inc., Fitbit Inc., Oura Health Ltd., Dexcom Inc., and Garmin Ltd. are some leading industry players in the Biohacking market.